Asset Details
Do you wish to reserve the book?
Choroidal metastasis as the first sign of small cell lung cancer: A case report
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Choroidal metastasis as the first sign of small cell lung cancer: A case report
Do you wish to request the book?
Choroidal metastasis as the first sign of small cell lung cancer: A case report
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Choroidal metastasis as the first sign of small cell lung cancer: A case report
2025
Overview
Metastases in the choroid originating from small cell lung cancer (SCLC) remain rare. The diagnosis of ocular metastases and primary lung tumors in individuals with SCLC can be challenging and time-consuming, particularly when their first symptoms present as ocular. The treatment of patients with ocular metastases of lung cancer is another clinical challenge in terms of primary tumor control and metastasis suppression. The current study presents the case of a 62-year-old man admitted to The Second Hospital of Jilin University (Jilin, China) for blurred vision. Based on subsequent clinical and pathological features of the patient, choroidal metastasis was suspected. Upon examination, the patient was diagnosed with serous retinal detachment, pleural effusion, choroidal metastases and SCLC of the right lung. Patients with the aforementioned condition receive chemotherapy and radiotherapy. First-line chemotherapy regimens consisted of etoposide and nedaplatin, while second-line regimens consisted of liposomal paclitaxel combined with lobaplatin. The condition of the patient was controlled during the first treatment period, which led to a temporary improvement in quality of life. However, the disease rapidly progressed, and the patient declined further treatment and ultimately succumbed to his illness. Visual symptoms may be the first indication of malignant tumors; therefore, ocular symptoms should be vigilantly monitored in patients diagnosed with malignant tumors. Furthermore, palliative care, psychological support and socioeconomic assistance are key to the quality of life of patients. Adoption of a patient-centered approach to provide comfort can also optimize treatment outcomes and improve the quality of life of patients.
